Wang Gang, Cui Hai-Lun, Liu Jun, Xiao Qin, Wang Ying, Ma Jian-Fang, Zhou Hai-Yan, Pan Jing, Tan Yu-Yan, Chen Sheng-Di
Department of Neurology& Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, No.197, Rui Jin Er Road, Shanghai, 200025, China.
BMC Neurol. 2018 Aug 22;18(1):122. doi: 10.1186/s12883-018-1122-4.
Chinese guidelines for management of Parkinson's disease (PD) have been issued and updated regularly since 2006. We undertook a cross-sectional survey to evaluate the impact of the latest edition (2014) on current approaches to the management of PD based on previous pilot works.
Seven hundred and seventeen participants, divided into 3 groups (GPs, Neurologists, and Specialists), recruited from 138 randomly chosen hospitals from 30 cities across China, participated by completing the questionnaire describing their current approaches before and after the guidelines were issued.
Considerable discrepancies in management were apparent across the three categories, with different selection of first-choice medication for PD patients. There were also variations in management of concurrent psychiatric symptoms and dementia. Notably, over 50% of participants reported improvements in PD recognition and management by following the guidelines.
The increasing use of Chinese clinical practice guidelines for PD management is having a positive impact on the optimization of care, which in turn offers important economic benefits.
自2006年以来,中国已定期发布和更新帕金森病(PD)管理指南。基于之前的试点工作,我们进行了一项横断面调查,以评估最新版本(2014年)对当前PD管理方法的影响。
从中国30个城市随机选取的138家医院招募了717名参与者,分为3组(全科医生、神经科医生和专科医生),通过填写描述指南发布前后其当前管理方法的问卷来参与调查。
三类医生在管理方面存在明显差异,对PD患者的首选药物选择不同。在并发精神症状和痴呆的管理方面也存在差异。值得注意的是,超过50%的参与者报告称遵循指南后在PD识别和管理方面有所改善。
中国PD管理临床实践指南的使用增加对优化护理产生了积极影响,进而带来了重要的经济效益。